{"id":"W4408803504","doi":"10.1016/j.annonc.2025.03.010","title":"Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Gilead Sciences; Novartis","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Palbociclib; Internal medicine; Cancer; Placebo; Gynecology; Pathology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036704,0.0002405123,0.0005562315,0.0000551279,0.0001289639,0.00001498612,0.0001441354,0.0001188143,0.00003577265],"category_scores_gemma":[0.0004734739,0.0001584188,0.00007716071,0.0001558761,0.0004536812,0.00009868414,0.00006312216,0.0002270214,9.000968e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000752257,"about_ca_system_score_gemma":0.000763886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001252643,"about_ca_topic_score_gemma":0.0009308888,"domain_scores_codex":[0.9983252,0.0001725147,0.000456262,0.0004500887,0.0002545002,0.0003414839],"domain_scores_gemma":[0.9970931,0.00164425,0.0003801255,0.0003517476,0.0003725313,0.0001582439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7782205,0.0003104166,0.0748503,0.00003698848,0.0005426537,0.000007338609,0.0006625138,0.00003598135,0.00002571743,0.00005847092,0.001463008,0.1437861],"study_design_scores_gemma":[0.246152,0.003410287,0.7373694,0.0003013081,0.0003134906,7.173572e-7,0.0002220126,0.00002575995,0.0001747255,0.0008961927,0.01095667,0.0001775],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9625065,0.0006563428,0.00004191774,0.03239397,0.0005434735,0.001386212,0.002373683,0.0000258896,0.00007197606],"genre_scores_gemma":[0.9936261,0.0003583366,0.001518565,0.002995033,0.0006683149,0.0004012219,0.0001981605,0.00003648515,0.0001978264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6625191,"threshold_uncertainty_score":0.6460133,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05246479190285808,"score_gpt":0.3622241662839321,"score_spread":0.309759374381074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}